To help us continue to improve our service, this web site uses cookies. They cannot be used to identify you. Using this site implies an agreement to continue accepting them. For more details please see managing the cookies we use.  

About Us

Trust Board Papers

These papers carry a general and press embargo until after the Board of Directors meeting has been held and no discussion concerning them will be entered into until that time.

PUBLIC MEETING OF THE BOARD OF DIRECTORS
OF THE ROYAL UNITED HOSPITAL, BATH NHS TRUST
TIME: 10:00 – 12:00
DATE: Wednesday, 27 September 2017
VENUE: Board Room, Oasis Centre, RUH

A G E N D A

All documents open in a new window

Agenda

Opening Business

Agenda Item Presenter Attachment
Chairman's Welcome and Apologies Brian Stables, Chairman

Verbal

Written Questions from the Public Brian Stables, Chairman

Verbal

Declarations of Interests Brian Stables, Chairman

Verbal

Minutes of the Public Trust Board meeting held in public on 26 July 2017 Brian Stables, Chairman

Paper 4

Action List and Matters Arising Brian Stables, Chairman

Paper 5

back to top

Quality: Patient Safety, Effectiveness & Experience

Agenda Item Presenter Attachment
Patient Story: Clostridium Difficile Sharon Manhi, Head of Patient Experience

Presentation

Quality Report (inc. presentation on Falls Pathway) Helen Blanchard, Director of Nursing and Midwifery

Paper 7

Quarterly Patient Experience Update Report Helen Blanchard, Director of Nursing and Midwifery

Paper 8

End of Life Care Annual Report Helen Blanchard, Director of Nursing and Midwifery

Paper 9

Medical Revalidation Annual Board Report Tim Craft, Medical Director

Paper 10

back to top

Operational Performance and Use of Resources

Agenda Item Presenter Attachment
Operational Performance Report Francesca Thompson,
Chief Operating Officer/Claire Buchanan Director of Human Resources

Paper 11

RTT Position Report Francesca Thompson, Chief Operating Officer

Paper 12

4 Hour Performance Report Francesca Thompson, Chief Operating Officer

Paper 13

Finance Report Sarah Truelove, Deputy Chief Executive and Director of Finance

Paper 14

back to top

Corporate Governance / Risk / Regulatory

Agenda Item Presenter Attachment
Clinical Governance Committee Update Report Jeremy Boss, Non-Executive Director

Paper 15

Non-Clinical Governance Committee Update Report Joanna Hole, Non-Executive Director

Paper 16

Management Board Update Report James Scott, Chief Executive

Paper 17

Management Board Terms of Reference James Scott, Chief Executive

Paper 18

Fit for the Future Board Terms of Reference Xavier Bell, Board of Directors Secretary

Paper 19

Health & Safety Quarterly Report James Scott, Chief Executive

Paper 20

Guardian of Safe Working Quarterly Update Report Tim Craft, Medical Director

Paper 21

Complaints Annual Report Helen Blanchard, Director of Nursing and Midwifery

Paper 22

Review Board of Directors Workplan Xavier Bell, Board of Directors Secretary

Paper 23

Declaration of Interest Policy Xavier Bell, Board of Directors

Paper 24

back to top

Closing Business

Agenda Item Presenter Attachment
Chief Executive's Report James Scott, Chief Executive

Paper 25

Chairman's Report Brian Stables, Chairman

Paper 26

Items for Assurance Committees Brian Stables, Chairman

Discussion

Resolution to exclude member of the public.

That representatives of the press and other members of the public be excluded from the remainder of this meeting having regard to the confidential nature of the business to be transacted, publicity of which would be prejudicial to the public interest.

Business to be discussed in private session includes:

  • Detailed financial reports
  • Commercially in confidence reports
Brian Stables, Chairman

Verbal

back to top

Next Meeting:

Next Meeting:
Wednesday 25 October 2017
Venue:
RUH Board Room, Oasis Centre, Royal United Hospital, Bath

Under the provision of Section 1, sub-section 2, of the Public Bodies Admission to Meetings Act 1960, the public may be excluded from this meeting for such a period as the Board of Directors is in committee on the grounds that publicity would prove prejudicial to the public interest by reason of the confidential nature of the business to be transacted.

back to top